Klotho Neurosciences, Inc. continues to strengthen its advisory teams with recent new additions of Neuroscience and Big Pharma leaders to Scientific Advisory Board and Board
Projecting $4.0M in net revenue for Q1 2025—up 170% from the prior year—and expects to achieve positive cash flow in the same quarter Key Highlights:
IRVINE, Calif., Dec. 04, 2024 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding
IRVINE, Calif., Dec. 02, 2024 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today announced additional favorable data regarding its lead assay VitaGraft™, which
Peer-reviewed article highlights potential treatment for OLP with focus on localized drug delivery PITTSBURGH, Dec. 03, 2024 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq:
Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise NEW YORK, Dec. 03, 2024 – PRISM MediaWire – Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based
NEW YORK, Dec. 03, 2024 – PRISM MediaWire – AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm,
Next Phase Pilot Study Jackson Center, PA, December 2, 2024 – PRISM MediaWire – Halberd Corporation (OTC PINK: HALB) previously reported results of a recently
StemSation International announced today the completion of the acquisition of 100% of the private marketing company, Gorilla Marketing Group, LLC Plantation, Florida, December 2, 2024
Skyborne’s Costin Airport Grant Infrastructure Project Has Been Completed for The Near Future Build of New Hangar Gulf County, FL, December 2, 2024 – PRISM
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
